Person who experienced the adverse event (patient)
| Event ID | CASE | I F COD | FOLL SEQ | IMAGE | EVENT DT | MFR DT | FDA DT | REPT COD | MFR NUM | MFR SNDR | AGE | AGE COD | GNDR COD | E SUB | WT | WT COD | REPT DT | OCCP COD | DEATH DT | TO MFR | CONFID | REPORTER COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 6524169 | 7235363 | F | 6524169-8 | 20090107 | 20091229 | 20091231 | EXP | UG-B.I. PHARMACEUTICALS,INC./RIDGEFIELD-2009-BP-14616BP | B.I. PHARMACEUTICALS,INC./RIDGEFIELD | 33 | YR | F | Y | 20091231 | OT |
Drug(s) used by person
| Event ID | DRUG SEQ | ROLE COD | DRUGNAME | VAL VBM | ROUTE | DOSE VBM | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 6524169 | 1012889268 | PS | VIRAMUNE | 1 | ORAL | 400 MG | 020636 | ||||
| 6524169 | 1012889269 | SS | VIREAD | 1 | ORAL | 30 MG | |||||
| 6524169 | 1012889270 | C | ALUVIA | 2 | 1500 MG |
Indications of drugs used
| Event ID | DRUG SEQ | INDI PT |
|---|---|---|
| 6524169 | 1012889268 | ANTIVIRAL TREATMENT |
| 6524169 | 1012889269 | ANTIVIRAL TREATMENT |
Outcome of event
| Event ID | OUTC COD |
|---|---|
| 6524169 | OT |
Reactions reported
| Event ID | PT |
|---|---|
| 6524169 | STILLBIRTH |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|
| 6524169 | 1012889268 | 20070709 | |||
| 6524169 | 1012889269 | 20070709 |